Related Experiment Videos
Influence of cefotaxime on Staphylococcus aureus with respect to their interaction with macrophages
A M Cuffini1, N A Carlone, V Tullio
1Institute of Microbiology, University of Turin, Torino, Italy.
Abstract:
Many antibiotics in addition to their direct effect on bacteria can modulate host defence in different ways. The influence of cefotaxime on the phagocytic and bactericidal activity of mouse peritoneal macrophages was investigated. At concentrations of half the MIC the antibiotic caused macrophages to kill intracellular Staphylococcus aureus at a higher level than did macrophages without drug. Bacteria pretreated with cefotaxime became more sensitive to macrophage phagocytic and bactericidal activity. Macrophages taken from mice receiving intravenous cefotaxime showed greater phagocytic capacity than those from control mice.
Insights
The antibiotic cefotaxime enhances macrophage immune response, boosting their ability to eliminate Staphylococcus aureus. This suggests cefotaxime may improve host defense beyond its direct antibacterial action.
Area of Science:
- Immunology
- Microbiology
- Pharmacology
Background:
- Antibiotics can influence host immune responses, not just target bacteria.
- Understanding these host-modulating effects is crucial for optimizing antibiotic therapy.
Purpose of the Study:
- To investigate the impact of cefotaxime on macrophage phagocytic and bactericidal activity.
- To determine if cefotaxime enhances the host's ability to clear Staphylococcus aureus infections.
Main Methods:
- Mouse peritoneal macrophages were used to assess phagocytosis and killing of Staphylococcus aureus.
- Antibiotic concentrations at half the Minimum Inhibitory Concentration (MIC) were tested.
- In vivo studies involved administering cefotaxime intravenously to mice.
Main Results:
- Cefotaxime significantly increased the killing of intracellular Staphylococcus aureus by macrophages.
- Pretreatment of bacteria with cefotaxime enhanced their susceptibility to macrophage-mediated clearance.
- Macrophages from cefotaxime-treated mice exhibited increased phagocytic capacity compared to controls.
Conclusions:
- Cefotaxime demonstrates immunomodulatory effects, enhancing macrophage function against Staphylococcus aureus.
- The findings suggest a dual role for cefotaxime, acting both directly on bacteria and indirectly by boosting host defenses.
- Cefotaxime's ability to augment innate immunity warrants further investigation for therapeutic applications.